Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-04
DOI
10.1038/s41467-021-22740-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential
- (2020) Kara A. Moser et al. Genome Medicine
- A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
- (2020) Lawrence T. Wang et al. IMMUNITY
- Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
- (2019) Tamaki Kobayashi et al. mSphere
- Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis
- (2019) Joshua M. Obiero et al. mSphere
- PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47)
- (2019) Hikaru Nagaoka et al. Scientific Reports
- Immunization with merozoite surface protein 2 fused to a Plasmodium-specific carrier protein elicits strain-specific and strain-transcending, opsonizing antibody
- (2019) Jacqueline S. Eacret et al. Scientific Reports
- Antibody Profiling by Proteome Microarray with Multiplex Isotype Detection Reveals Overlap between Human and Aotus nancymaae Controlled Malaria Infections
- (2018) Omid Taghavian et al. PROTEOMICS
- A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
- (2018) Alison Roth et al. Nature Communications
- Malaria prevention: from immunological concepts to effective vaccines and protective antibodies
- (2018) Ian A. Cockburn et al. NATURE IMMUNOLOGY
- Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
- (2017) Mahamadou S Sissoko et al. LANCET INFECTIOUS DISEASES
- Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
- (2017) Benjamin Mordmüller et al. NATURE
- Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
- (2017) Kirsten E. Lyke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Determinants of Malaria Transmission at the Population Level
- (2017) Teun Bousema et al. Cold Spring Harbor Perspectives in Medicine
- Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1
- (2016) Dominika J. Maskus et al. Scientific Reports
- Plasmodium falciparumProtein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya
- (2015) Arlene E. Dent et al. JOURNAL OF INFECTIOUS DISEASES
- Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres
- (2015) Benjamin Mordmüller et al. MALARIA JOURNAL
- Identification of important interacting proteins (IIPs) in Plasmodium falciparum using large-scale interaction network analysis and in-silico knock-out studies
- (2015) Madhumita Bhattacharyya et al. MALARIA JOURNAL
- Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites
- (2015) Remko Schats et al. PLoS One
- Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates
- (2015) Rhea J. Longley et al. Scientific Reports
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
- (2014) PLOS MEDICINE
- Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity
- (2013) E. M. Bijker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
- (2013) R. A. Seder et al. SCIENCE
- Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis
- (2013) Philip L. Felgner et al. Scientific Reports
- Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
- (2011) Meta Roestenberg et al. LANCET
- Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity
- (2011) J. E. Epstein et al. SCIENCE
- Development of a metabolically active, non-replicating sporozoite vaccine to preventPlasmodium falciparummalaria
- (2010) Stephen L. Hoffman et al. Human vaccines & immunotherapeutics
- Protection against a Malaria Challenge by Sporozoite Inoculation
- (2009) Meta Roestenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now